A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer. (Q33405378)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer. |
scientific article |
Statements
A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer (English)
Andreas Gröschel
Martin Sebastian
Stefan Andreas
Thomas Müller
Folker Schneller
Sylvia Guetz
Corinna Eschbach
Sabine Bohnet
Monika I Leschinger
Martin Reck
16 January 2013